Trexquant Investment LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$1,213,926
-66.8%
14,258
-67.7%
0.03%
-68.0%
Q1 2023$3,658,129
-28.6%
44,207
-32.1%
0.10%
-31.0%
Q4 2022$5,120,194
+380.3%
65,101
+352.2%
0.14%
+291.9%
Q3 2022$1,066,000
-87.1%
14,396
-88.6%
0.04%
-90.0%
Q2 2022$8,241,000
+3715.3%
126,439
+3604.6%
0.37%
+3590.0%
Q1 2022$216,000
-48.2%
3,413
-56.6%
0.01%
-61.5%
Q4 2021$417,000
+19.8%
7,869
+168.8%
0.03%
-29.7%
Q4 2020$348,000
-17.9%
2,928
-39.7%
0.04%
+37.0%
Q3 2020$424,000
-42.5%
4,857
-24.3%
0.03%
-38.6%
Q4 2019$737,000
-22.3%
6,417
-14.7%
0.04%
-46.3%
Q3 2019$949,000
-10.3%
7,526
-37.8%
0.08%
+9.3%
Q1 2019$1,058,000
+344.5%
12,093
+481.4%
0.08%
+316.7%
Q3 2018$238,000
-92.7%
2,080
-94.3%
0.02%
-92.0%
Q2 2018$3,261,000
+139.6%
36,365
+95.4%
0.23%
+137.9%
Q1 2018$1,361,000
+194.6%
18,609
+80.6%
0.10%
-18.1%
Q3 2017$462,000
+71.7%
10,302
+54.2%
0.12%
+169.8%
Q4 2016$269,000
-25.5%
6,682
-46.3%
0.04%
-8.5%
Q2 2016$361,000
-7.7%
12,445
+2.9%
0.05%
+38.2%
Q3 2015$391,00012,1000.03%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders